metformin has been researched along with Stomatitis in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Stomatitis: INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin (Met) is a first-line and essential treatment for type 2 diabetes, with anti-inflammatory effects." | 1.72 | Metformin protects 5-Fu-induced chemotherapy oral mucositis by reducing endoplasmic reticulum stress in mice. ( Chen, Y; Li, X; Ma, R; Shan, E; Shan, J; Sun, H; Zhang, J; Zhou, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, H | 1 |
| Zhou, Y | 1 |
| Ma, R | 1 |
| Zhang, J | 1 |
| Shan, J | 1 |
| Chen, Y | 1 |
| Li, X | 1 |
| Shan, E | 1 |
1 other study available for metformin and Stomatitis
| Article | Year |
|---|---|
Metformin protects 5-Fu-induced chemotherapy oral mucositis by reducing endoplasmic reticulum stress in mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; | 2022 |